Study Details Decline in Febuxostat Use Following Addition of Boxed Warning by FDA
A new study is providing clinicians with a breakdown of the real-world impact of the 2019 labeling changes to febuxostat (Uloric) following the U.S. Food and Drug Administration (FDA)’s addition …